| Customization: | Available |
|---|---|
| Powder: | Yes |
| Purity: | >99% |
|
Still deciding? Get samples of US$ 500/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Indication: AIDS
Dolutegravir is taking a drug in phase III clinical trials (http://huaronggroup.en.made-in-china.com) has reached with Merck HIV/AIDS drugs leite, wei (Raltegravir, Isentress) match * *.
Rettgwett was taken twice a day, both of which were inhibitors of HIV integrase.
FDA officials say that people infected with HIV need to be targeted on a case-by-case basis and that Tivicay will offer new options for patients.
In a study conducted a year ago, 88 percent of patients who received 48 weeks of Tivicay** showed ** improvement
){kind=link}